Facebook picto   picto linkdink   picto tiwter


EDAP TMS, the World Leader in Therapeutic Ultrasound

A global leader in therapeutic ultrasound and present in the market for almost 40 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. EDAP TMS is actively operating worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. By constantly investing in Research & Development, partnering with INSERM French public laboratory and internationally renowned medical research institutions, EDAP TMS has developed a strong valuable patent portfolio based on its innovative technologies.

HIFU (High Intensity Focused Ultrasound)

With its complete range of Robotic HIFU devices, Ablatherm® Fusion and Focal One® [1], EDAP TMS is the most innovative company in non-invasive treatment of prostate conditions*. By combining the latest technologies in imaging and treatment modalities, EDAP TMS introduced the Focal One® in the U.S. in 2018 as the answer to all requirements for focal ablation of prostate tissue as a complement to the existing Ablatherm®.

ESWL (Extracorporeal ShockWave Lithotripsy)

As a pioneer and key player in the field of Extracorporeal ShockWave Lithotripsy, EDAP TMS introduced the first modular lithotripter. The latest generation of shockwave source (Electroconductive Technology) and stone localization (Visio-Track) are utilized exclusively by EDAP TMS in its Sonolith® range of ESWL systems (Sonolith® i-sys and Sonolith® i-move).

Stone Laser

To offer a complete range of minimally invasive solutions covering the full scope of urinary tract stone indications, EDAP TMS has integrated in its portfolio the Laserlith® i-dust, a user-friendly 30W Holmium:YAG Surgical Laser.


[1] Ablatherm® and Focal One® are CE marked and indicated in Europe and other parts of the world outside of the U.S. for the treatment of localized Prostate Cancer. In the United States, Ablatherm® and Focal One® are indicated for the ablation of prostate tissue.